Panacea Acquisition Corp. II (PANA)

NASDAQ: PANA · IEX Real-Time Price · USD
9.69
0.00 (0.00%)
May 12, 2022 12:00 AM EDT - Market closed
Market Cap228.15M
Revenue (ttm)n/a
Net Income (ttm)-736,297
Shares Out23.54M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6
Open9.73
Previous Close9.69
Day's Range9.69 - 9.73
52-Week Range9.60 - 10.23
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About PANA

Panacea Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.

IndustryBlank Check / SPAC
IPO DateApr 7, 2021
Employees3
Stock ExchangeNASDAQ
Ticker SymbolPANA
Full Company Profile

News

Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering

SAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition,...

1 year ago - GlobeNewsWire

Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio

SAN FRANCISCO--(BUSINESS WIRE)--Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 333...

1 year ago - Business Wire

4 SPAC Mergers: What The KBLM, ACAM, PANA And SMMC Deals Mean For Investors

Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Partners Acquisition Corp. (NASDAQ: ACAM), Panacea Acquisition Corp. (NYSE: P...

Other symbols:ACAM
1 year ago - Benzinga